The somatic fusion of TMPRSS2 to ETS oncogenes is a common event in prostate cancer (PCa). We hypothesized that defects in DNA repair may lead to an increase of chromosomal rearrangements and thus to the occurrence of ETS oncogene fusion. We have previously conducted a genome-wide linkage analysis in TMPRSS2-ERG fusion-positive PCa families, revealing potential susceptibility loci on chromosomes 5q14, 9q21, 10q26, 11q24, 12q15, 13q12, 18q, and Xq27. In the present study, nine candidate genes from these regions were selected from the context of DNA repair and screened for mutations in TMPRSS2-ERG fusion-positive families. Thirteen nonsynonymous variants, 5 of which had a minor allele frequency of <0.05, were genotyped in 210 familial cases, 47 of which with a known TMPRSS2-ERG status, 329 sporadic cases, and 512 controls. Significant association of TMPRSS2-ERG fusion-positive PCa was found with rare variants in the genes for POLI [variant F532S: P = 0.0011; odds ratios (OR), 4.62; 95% confidence interval (95% CI), 1.84-11.56] and ESCO1 (variant N191S: P = 0.0034; OR, 4.27; 95% CI, 1.62-11.28). Additional findings, regardless of TMPRSS2-ERG status, were the overrepresentation of a rare BRCA2 variant (V2728I: P = 0.03; OR, 6.16; 95% CI, 1.19-32.00) in familial PCa and of a common allele of RMI1 (variant N455S: P = 0.02; OR, 1.33; 95% CI, 1.04-1.70) in unselected PCa cases. The DNA repair genes POLI and ESCO1 are proposed as susceptibility genes for TMPRSS2-ERG fusion-positive PCa that warrant further investigation. (Cancer Epidemiol
Introduction
Prostate cancer (PCa) is the most frequent tumor and the third leading cause of cancer-related death in men in the western world. PCa has the highest heritability (0.42) among common carcinomas (1) , and a positive family history for PCa is one of its best established risk factors (2) . Recent genome-wide association studies reproducibly revealed low-risk common variants that have a putative cumulative effect (see ref. 3 for review), but to date, no high-risk gene is known, which could explain a significant portion of the familial clustering of PCa. Linkage analyses, which were done to identify such genes, have been hampered by the strong disease heterogeneity even if scans were subgrouped according to epidemiologic and clinical criteria (see ref. 4 for review). An alternative approach could be to focus on the molecular characteristics of the tumor. Thus, stratification for its crucial events could facilitate the enrichment of specifically involved susceptibility genes that are closely correlated with a distinct underlying pathomechanism.
The recently discovered TMPRSS2-ERG fusion in PCa (5) might be such a crucial event for PCa tumorigenesis, as an analogous activation of the ERG oncogene is already known to be an initial event in leukemia (6) and Ewing's sarcoma (7) . Both TMPRSS2 and ERG are located on chromosome 21q22 with about 2.8 Mb of distance and about 40% to 60% of all PCas harbor their fusion. In our previous study, we found evidence for an inherited susceptibility for TMPRSS2-ERG fusion-positive PCa and obtained several candidate loci at 5q14, 9q21, 10q26, 11q26, 12q21, 13q12, 18q, and Xq27 by linkage analysis (8) . We hypothesize that susceptibility for the oncogenic fusion could be explained by a generally elevated chromosomal instability with subsequent selection for growth advancing rearrangements. Therefore, genes within the context of chromosomal stability and DNA repair could represent candidate susceptibility genes, as defects in these genes may lead to an increase of chromosomal rearrangements, thus promoting the occurrence of the TMPRSS2-ERG fusion in PCa. In the present study, the genes APTX, BCCIP, BRCA2, ESCO1, FANCG, POLI, RMI1, SMC5, and XRCC4, all selected from candidate linkage regions, were screened for germ-line variations, and 13 amino acid alterations were subjected to casecontrol comparisons.
Materials and Methods
Patients. All individuals described in this report are participants in the Prostate Cancer Genetics Project of the University of Ulm. All probands were of Caucasian descent. Informed consent, according to the Institution Review Board at the University of Ulm, was mandatory. For the recruitment of families with PCa clustering, urologists from all over Germany were asked to inform patients with PCa about our project and to motivate them to contact our institution. The self-reported family history of PCa of the index proband was used to identify PCa families. A detailed family questionnaire was used as a guide for the recruitment of affected and relevant unaffected relatives. In all cases, the diagnosis of PCa was confirmed by a histopathologic report or by other suitable medical records. Familial PCa patients were predominantly contributed by Urological Surgical Departments from Southern Germany and the majority were treated by radical prostatectomy. For association test, a total number of 210 families were included, of which 82 families (39%) comprised two affected relatives, 69 (33%) had three, 43 (20%) had four, and 16 (8%) had five or more affected relatives. The index patients' mean age at diagnosis was 62.9 y (range, 40-80 y). For the sequencing of candidate genes, index probands were chosen from 10 independent families with at least two TMPRSS2-ERG fusion-positive PCa cases that were used for a genomewide linkage analysis (8) . Two additional fusion-positive index probands were screened, of which the fusion status of affected relatives was unknown. Of all 210 familial index cases, 47 were available for the determination of the fusion status. Thirty-two were TMPRSS2-ERG fusion positive (including the 12 cases of the mutation analysis sample) and 15 were fusion negative. Sporadic cases, where a negative family history was reported, were recruited from a radical prostatectomy series carried out in the Clinic of Urology in Ulm (n = 329). The mean age of diagnosis was 63.7 y (range, 42-84). For controls, we used 298 population controls and 214 healthy, age-matched men, who were not diagnosed with PCa before. The mean age of the age-matched controls at the time of sampling was 58.4 y (range, 33-88).
Detection of TMPRSS2-ERG Fusion Status. The fusion of TMPRSS2 and ERG, both located on chromosome 21q22, was detected by a dual-color break apart interphase fluorescence in situ hybridization assay as described elsewhere in detail (9) .
Candidate Regions and Gene Selection. Candidate regions were taken from genome-wide linkage data, where nominal significance (P < 0.05) in both parametric and nonparametric linkage results (LOD and NPL score, respectively) was reached. This was fulfilled for loci on (Table 1) , which were obviously involved in DNA repair. Two prominent DNA repair genes (BRCA2 and XRCC4) were investigated in addition, as they were located within linkage peaks (13q12 and 5q14, respectively) beyond the reported criteria (see Table 1 ).
Genetic Analysis. Genomic DNA was extracted from peripheral blood lymphocytes by standard procedures for the majority of probands (n = 1044; 99.3%) or in exceptional cases (n = 7; 0.7%) from paraffin-embedded tissues using the QIAamp DNA FFPE Tissue kit (Qiagen) as recommended by the manufacturer. The genomic DNA served as template for PCR amplification of the coding regions of APTX, BCCIP, BRCA2, ESCO1, FANCG, POLI, RMI1, SMC5, and XRCC4. The primer sequences and PCR conditions will be given on request. PCR samples were purified by Multiscreen PCR96 filtration membrane plates (Millipore). For sequencing, we used the BigDye version 3.1 reagent (Applied Biosystems) as recommended by the manufacturer in a total volume of 5 μL. Samples were finally filtrated by Montage Seq96 plates (Millipore) and analyzed on an ABI3100 instrument. Individual sequences were aligned to the genomic reference sequences of National Center for Biotechnology Information Build 36.3. Single-nucleotide polymorphism genotyping was done using the Taqman Genotyping Mastermix (Applied Biosystems) in a total volume of 5 μL with Taqman SNP Genotyping Assays or Custom SNP Genotyping Assay (Applied Biosystems) on a 384-well 7900HT Fast RealTime PCR System (Applied Biosystems). PCR conditions were according to the manufacturer's protocol with 45 cycles. An oligo(CGA) n repeat in POLI was genotyped by means of a 6-FAM-labeled PCR amplification and subsequent length detection with an ABI3100 system (Applied Biosystems).
Statistical Analyses. Deviation from Hardy-Weinberg equilibrium was checked with the χ 2 test according to Pearson. 6 Associations between genotypes and disease status were assessed by unconditional logistic regression using the software package StatView (SAS). Dominant and recessive models were tested and the more significant was presented. Odds ratios (OR), their 95% confidence intervals (95% CI), and the corresponding P values are given. Although the study is explorative in nature, we applied correction for multiple testing to further validate our results. Bonferroni correction was done to account for 13 tests (13 variants), resulting in an adjusted significance level of 0.0038 (0.05/13). With respect to the small number of fusion-positive cases, empirical P values were determined by permutation tests (10,000 replicates) using maxT method of the PLINK software 7 (version 1.06). Results from logistic regression for a dominant model are reported taking into account the testing of 13 variants.
Results and Discussion
Variability in DNA Repair Genes in TMPRSS2-ERG Fusion-Positive Families. A previous linkage analysis in TMPRSS2-ERG fusion-positive PCa families suggested several potentially predisposing regions at 5q14, 9q21, 10q26, 11q26, 12q21, 13q12, 18q, and Xq27. As variability in the individual DNA repair capacity would be a plausible predisposing mechanism for oncogenic chromosomal rearrangements, we systematically sought the regions of interests for candidate genes that were derived from the context of DNA repair. Table 1 shows an overview of all target regions, their total number of genes, and the selected candidates. Note that not all regions contained obvious DNA repair genes. Apart from our hypothesis, other mechanisms, and thus other sets of genes, might be involved in TMPRSS2-ERG predisposition. One DNA damage-related pathway could be represented by the p53-dependent induction of apoptosis. Two genes of this mechanism, the DYRK2 kinase upstream of p53, and P53AIP1, which was found mutated in PCa (10), reside in our candidate regions 12q21 and 11q26, respectively. For the present mutation analysis, we chose the nine DNA repair genes APTX, BCCIP, BRCA2, ESCO1, FANCG, POLI, RMI1, SMC5, and XRCC4. A total number of 111 coding exons were sequenced in 12 familial index probands with TMPRSS2-ERG fusion. No nonsense, frameshift, or other obviously deleterious mutation was found. For APTX, BCCIP, and FANCG, no variations of the genomic sequence in exons or splice sites were observed. A total number of 20 germ-line variants were identified in BRCA2, ESCO1, POLI, RMI1, SMC5, and XRCC4. As listed in Table 2 , 14 variants altered the encoded peptide by either amino acid exchange, codon deletion/insertion (POLI D17del), or splice site alteration (XRCC4 IVS7-1G>A).
Association of PCa with Amino Acid Variations in DNA Repair Genes. A case-control study was done for 13 variations (Table 2) to clarify their relevance for PCa. Five of them had a minor allele frequency of <5%. All variations were in Hardy-Weinberg equilibrium in controls. For association tests, subgroups of PCa cases were compared with the controls: (a) all cases, including familial index and sporadic probands, (b) cases split by family history, and (c) familial index probands with a known positive fusion status. Nominally significant associations in at least one of the tests, as shown in Table 3 , were found in BRCA2, ESCO1, POLI, and RMI1, of which the ESCO1 and POLI variants remained significant after correction Table 3 . Genotype-specific OR, 95% CI, and nominal P values of associated variants (selection) when comparing controls with all cases, sporadic cases, familial index cases, or TMPRSS2-ERG fusion-positive cases, respectively for multiple testing. To avoid pitfalls inherent in multiple testing and small numbers, empirical P values were obtained for fusion-positive cases versus all controls by permutation tests. Nominal and corrected P values (Table 3 ) turned out to be very similar to those calculated directly.
RMI1. The RMI1-encoded protein assembles with the Bloom helicase (BLM) and the topoisomerase TOP3A to a complex that is required for accurate dissolution of Holliday junctions during homologous recombination repair (11, 12) . Constitutive BLM deficiency causes a tumor susceptibility syndrome (OMIM #210900), and recently, variations in all three BLM complex genes were suggested as risk modifiers for several types of cancer (13) . In our cohort, the RMI1 variant 455S of the common polymorphism N455S was associated with PCa risk when all unselected cases were compared with controls (OR, 1.33; P = 0.02; recessive model). The observed effect was stronger in sporadic cases (OR, 1.43; P = 0.01; recessive model), but no enrichment of 455S genotypes was present when selecting on fusion-positive cancer ( Table 3) . As the association observed here reached only nominal significance, and the risk effect seems small (OR), the RMI1 allele 455S could be considered as a mildly predisposing candidate variant for PCa in general.
BRCA2. Deleterious mutations in BRCA2 account for a serious risk for PCa in male carriers (14, 15) and are correlated with an earlier age of onset (16) as well as with a poor prognosis (17) . BRCA2 was searched for mutations because of some evidence of linkage at 13q12 (NPL = 2.32; P = 0.01) in our previous analysis of TMPRSS2-ERG fusion-positive families. Of 3 rare amino acid substitutions (Table 2) , which were found in 12 screened index probands, the exchange BRCA2 V2728I seemed overrepresented in the familial cases, unselected for fusion status, compared with controls. However, due to the rarity of the risk allele, a larger sample size would be needed to clarify the role of the variant in PCa, especially in the familial and the TMPRSS2-ERG fusion-positive subgroups.
ESCO1. ESCO1 is essential for sister chromatid pairing, thereby preventing chromosomal breakage during S phase (18) . Moreover, ESCO1-mediated cohesion in response to DNA double-strand breaks was shown in yeast (19) . We found the rare ESCO1 N191S variant significantly overrepresented in our familial PCa subset (OR, 1.95; P = 0.03). When stratifying on TMPRSS2-ERG fusion-positive cases, the 191S allele accumulates even stronger, resulting in a 4-fold odds for fusion-positive PCa (P = 0.0034). It has been shown in yeast that the disruption of the ESCO1 protein impedes cohesion during G 2 -M phase (19) after restriction-induced double-strand breaks. As cohesion is essential for recombinational repair, one major mechanism for error-free restoration of chromosomal integrity, ESCO1 failure would mean an elevated number of broken or improperly repaired chromosomes. ESCO1 represents a candidate gene that has not been implicated in cancer thus far.
POLI. Polymerase iota is a member of the translesion synthesis machinery and facilitates to bypass DNA lesions via Hoogsteen base pairing (see ref. 20 for review). POLI was suggested as a candidate tumor susceptibility gene in two different mouse model approaches for lung (21) and colorectal cancer (22) . In our study, we observed a POLI germ-line variant (F532S) significantly enriched in probands with TMPRSS2-ERG fusion (OR, 4.6; P = 0.0011). Although 532S is an infrequent allele (5.7% carriers in controls), it was discovered in 3 of 12 (25%) index probands of our mutation analysis sample positive for TMPRSS2-ERG. Genotyping of the further 35 unrelated familial cases again revealed a high frequency of carriers (4 of 20; 20%) in fusion-positive PCa. F532S was not present in TMPRSS2-ERG fusion-negative cases (n = 15). The physiologic consequence of 532S is unknown. However, it is located in a functional domain, the ubiquitin binding motif one (UBM1), which is essential for proper recruitment of POLI to DNA repair foci (23) . POLI is present at stalled replication forks, physiologically occurring incidents that, if unresolved, result in the disruption of the DNA double strand. If POLI is relevant to overcome stalled replication forks, its functional loss would increase the number of double-strand breaks and, thus, the general rate of chromosomal rearrangements.
Conclusion
Genetic variants in DNA repair genes (e.g., BRCA2 mutations) are known to contribute to PCa risk, albeit their corresponding somatic mechanism in tumorigenesis is not yet fully understood. The oncogenic TMPRSS2-ETS fusion could represent a concrete outcome of insufficient genome integrity as a missing link between DNA repair and PCa susceptibility. As a working hypothesis, and stratification method, we proposed that the fraction of TMPRSS2-ERG families reflects the patients with altered DNA repair in this otherwise genetically heterogeneous disease. We found support for this theory as (a) stratification for TMPRSS2-ERG fusion resulted in linked candidate regions and (b) therein variants in DNA repair genes enriched in that specific subgroup of families. A total number of 13 variants in DNA repair genes were tested in this study. Two of them, ESCO1 N191S and POLI F532S, withstand correction for multiple testing with Bonferroni as well as with permutation testing and maintained significantly associated with TMPRSS2-ERG fusion-positive PCa. Both encode proteins, which plausibly contribute to the avoidance and repair of DNA double-strand breaks, therefore protecting chromosomal stability and preventing translocation events such as the TMPRSS2-ERG fusion. Nevertheless larger sample sizes are needed to verify our findings and to refine the contributed risk ratios.
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